TotalMarketCap

Alterity Therapeutics

ATHENasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$41.515 M

$2.28 -6.56%

Close of 6 Nov 2026

As of 6 Nov 2026, Alterity Therapeutics (ATHE) has a market capitalization of $41.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

217,508,862

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #345Biomea FusionBMEA$42.6M
  2. #346Gain TherapeuticsGANX$42.1M
  3. #347Alterity TherapeuticsATHE$41.5M
  4. #348Actinium PharmaceuticalsATNM$41.2M
  5. #349Serina TherapeuticsSER$41.1M

What if Alterity Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,550,764

Per share 680,159× higher

Bitcoin $1.53T

$83,909.12

Per share 36,802× higher

Apple $5.02T

$275,465.80

Per share 120,818× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Alterity Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.